Clinical Trial Update: Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating bevacizumab and atezolizumab, with or without cobimetinib, in patients with untreated melanoma b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma Brain Metastases

Drugs mentioned

• Avastin (bevacizumab)
• Cotellic (cobimetinib)
• Tecentriq (atezolizumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: BRAF V600 Wild Type, Clinical Stage IV Cutaneous Melanoma AJCC v8 | Phase 2 | Status: ACTIVE_NOT_RECRUITING